Publication Name	World Journal of Gastroenterology
Manuscript ID	6158
Country	Sweden

Received	2013-10-06 17:59
Peer-Review Started	2013-10-07 11:58
To Make the First Decision	2013-11-04 20:05
Return for Revision	2013-11-05 19:48
Revised	2013-11-16 21:54
Second Decision	2013-12-05 19:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-12-06 11:49
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-01-16 11:36
Publish the Manuscript Online	2014-01-26 20:08

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Cysteinyl leukotrienes and their receptors: Bridging inflammation and colorectal cancer
Manuscript Source	Invited Manuscript
All Author List	Sayeh Savari, Katyayni Vinnakota, Yuan Zhang and Anita Sjölander
Funding Agency and Grant Number
Corresponding Author	Anita Sjölander, Professor, Division of Cell and Experimental Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, SE-205 02 Malmö, Sweden. anita.sjolander@med.lu.se
Key Words	Eicosanoids; Cysteinyl leukotrienes; CysLT1R; CysLT2R; Inflammation; Colorectal cancer
Core Tip	Despite several advances in diagnostic and therapeutic options, colorectal cancer (CRC) continues to be a major health problem and one of the leading causes of cancer-related deaths. The inflammatory milieu has been widely recognized as one of the enabling characteristics of cancer development. Cysteinyl leukotrienes are pro-inflammatory eicosanoids implicated in chronic inflammatory bowel diseases and CRC development. Hence, targeting cysteinyl leukotrienes and their receptors could provide alternative therapeutic approaches or be used in combination with existing therapies for more efficient treatment of CRC.
Publish Date	2014-01-26 20:08
Citation	Savari S, Vinnakota K, Zhang Y, Sj?lander A. Cysteinyl leukotrienes and their receptors: Bridging inflammation and colorectal cancer. World J Gastroenterol 2014; 20(4): 968-977
URL	http://www.wjgnet.com/1007-9327/full/v20/i4/968.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i4.968

Full Article (PDF)	WJG-20-968.pdf
Full Article (Word)	WJG-20-968.doc
Manuscript File	6158-Review.docx
Answering Reviewers	6158-Answering reviewer.pdf
Copyright License Agreement	6158-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	6158-Language certificate.pdf
Peer-review Report	6158-Peer review(s).pdf
Scientific Editor Work List	6158-Scientific editor work list.doc